AI system
- System
-
ŌURA ring (heart-rate and heart-rate-variability summaries) used within GluCare.Health's hybrid care model
- Model
-
Not assessed
- Release
-
Not assessed
- Application developer
-
Maker of the ŌURA ring (company not named in the paper)
- Role
-
Not assessed
- Configuration
-
Not assessed
- Inputs and outputs
-
Not assessed
- Autonomy
-
Not assessed
- Workflow
-
Continuous ring wear under a clinic hybrid care model in which staff review daily synced heart-rate and HRV summaries. Risk factors (type 2 diabetes, smoking) that led to a treadmill stress test. Access to ECG, 24-hour Holter and echocardiography to confirm and characterize the PVCs.
- Human oversight
-
Not assessed
- Relation to AI
-
The ring generated no alert and, per the paper, cannot detect PVCs. Clinicians read its heart-rate and HRV summaries twice. Once was before the stress test (an elevated resting heart rate seen in remote monitoring is listed among the reasons for testing). Once was retrospectively afterwards. The ECG, stress test and Holter made the diagnosis. The paper describes no machine-learning component, so whether an AI system was involved is not shown by the source text. The only source is the treating clinic's case report.
- AI contribution
-
The ring generated no alert and, per the paper, cannot detect PVCs. Clinicians read its heart-rate and HRV summaries twice. Once was before the stress test (an elevated resting heart rate seen in remote monitoring is listed among the reasons for testing). Once was retrospectively afterwards. The ECG, stress test and Holter made the diagnosis. The paper describes no machine-learning component, so whether an AI system was involved is not shown by the source text. The only source is the treating clinic's case report.
Benefits
- Outcome identifiers
-
Not assessed
- Benefit
-
a 24-hour Holter recorded 2,078 ventricular events (1.75% of beats, no couplets or runs)
- Category
-
Improved Physical Health
- Status
-
Not assessed
- Beneficiary groups
-
People.
- Beneficiaries
-
Not assessed
- Reach
-
Not assessed
- Distribution and access
-
Not assessed
- Duration
-
Not assessed
- Expected?
-
Yes
- Costs and harms
-
Not assessed
Measurement
- Studies
-
Not assessed
- Study design
-
Not assessed
- Measurement
-
Not assessed
- Setting and sample
-
Not assessed
- Measures
-
a 24-hour Holter recorded 2,078 ventricular events (1.75% of beats, no couplets or runs)
- Comparison
-
Not assessed
- Results
-
a 24-hour Holter recorded 2,078 ventricular events (1.75% of beats, no couplets or runs)
- Additional value from AI
-
Not assessed
- Limitations
-
Not assessed
- Denominators
-
Not assessed
- Materials for replication
-
Not assessed
Money
- Kind of value
-
Not assessed
- Amount
-
Not assessed
- Currency and prices
-
Not assessed
- Period and unit
-
Not assessed
- Realization
-
Not assessed
- Recipients and payers
-
Not assessed
- Gross or net
-
Not assessed
- Included costs
-
Not assessed
- Comparison
-
Not assessed
- Method
-
Not assessed
- Return and payback
-
Not assessed
People and places
- Participants
-
Developer: Maker of the ŌURA ring (company not named in the paper). Operator: GluCare.Health, Dubai.
- Jurisdictions
-
Benefit: Dubai,
United Arab Emirates. Developer: 
Finland. Operator: United Arab Emirates. - Ownership and control
-
Not assessed
- Dependencies
-
Not assessed
- Cross-border connections
-
Not assessed
- Geopolitical implications
-
Not assessed
Follow-up
- Conditions for replication
-
Clinicians act on wearable trend deviations. The clinic later wrote thresholds into its workflow (an RMSSD drop of more than 30% or a resting heart rate above 110 bpm prompts review). The patient keeps wearing and syncing the ring so that trends can be compared with a baseline.
- Replication attempts
-
Not assessed
- Later findings
-
The paper's own two-month and four-month follow-up (resting heart rate 83 to 74 bpm, RMSSD 15.2 to 32.8 ms) belongs to the first report; nothing published after it was found.
- Availability
-
Not assessed
- Institutional decision
-
Not assessed
- Grounds
-
Not assessed
- Action and result
-
Not assessed
- Success criterion
-
Not assessed
Evidence
- Source numbers
-
AIBD-0293-source-0001–0003
- Citations
-
Numbered references below.
- Language
-
Not assessed
- Source relationships
-
Operator
- Original evidence
-
Not assessed
- Access and versions
-
Not assessed
- Supported findings
-
Not assessed
- Evidence links
-
Not assessed
- Evidence strength
-
Not assessed
- Missing evidence
-
Not assessed
Grades
- Assessed benefits
-
People.
- Depth
-
People: 1.
- Reasons
-
People: One asymptomatic man had a low PVC burden (1.75%) characterized, judged benign, and managed with lifestyle change. The report documents no drug or procedure. The ring's share in prompting the work-up is stated inconsistently within the paper.
- Observed or intended
-
Not assessed
- Rubric
-
Not assessed
- Assessor and date
-
Not assessed
- Alternative assessments
-
Not assessed
- Fill
-
The deployer's account
Entry details
- Kind
-
Not assessed
- Related entries
-
Not assessed
- Field
-
Healthcare (cardiology; diabetes care). Consumer wearables.
- Purpose
-
The ring tracks heart rate, HRV and sleep for consumers. The clinic used those daily summaries as remote-monitoring markers in its diabetes program. The paper does not claim the ring was built to find arrhythmias.
- Dates
-
Date basis unassessed: 2024 (precision unassessed). Updated: 21 October 2026.
- Stage
-
Not assessed
- Version
-
SHA-256: d3b952e1827d…
References
- Other identifiers
-
Not assessed
- Category mappings
-
Not assessed
- Brief
-
Not assessed
- Revisions
-
4 revisions. Latest: 21 October 2026.
Sources
-
Case report Deployer
Zakaria H, Roman I, Almarzooqi I, Hashemi A (2025). Integrating Wearables Into a Hybrid Care Model: Continuous Remote Monitoring of a Diabetic Patient With Frequent Premature Ventricular Contractions Using an ŌURA Ring. Cureus 17(6):e86174 (PMC12268106).
While the ŌURA ring does not detect arrhythmias like PVCs, it supplies surrogate physiological markers, such as heart rate and HRV, that can support early clinical insight
The patient wore an ŌURA ring before, during, and after a treadmill stress test; however, data review was conducted retrospectively.
a treadmill stress test was pursued due to his high-risk profile, which included poorly controlled diabetes and an elevated resting heart rate observed during wearable-based remote monitoring